A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea. (EB-RH-02-11)
This study is currently recruiting participants.
Verified March 2012 by Enovate Biolife Pvt Ltd
Information provided by Enovate Biolife Pvt Ltd
First Received on March 2, 2012.
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: